Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. TransCode Therapeutics Inc’s current trading price is -99.85% away from its 52-week high, while its distance from the 52-week low is 6.25%. The stock’s price range during this period has varied between $0.56 and $392.00. The company, active in the Healthcare sector, saw a trading volume of around 0.53 million for the day, considerably lower average daily volume of 0.63 million observed over the last three months.
TransCode Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $392.00 on 04/05/23, and the lowest price during that time was $0.56, recorded on 02/06/24.
How Financial Performance Impacts Market Capitalization
TransCode Therapeutics Inc (RNAZ) has experienced a quarterly decline of -92.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.91M and boasts a workforce of 19 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.3243, with a change in price of -17.0450. Similarly, TransCode Therapeutics Inc recorded 448,680 in trading volume during the last 100 days, posting a change of -96.63%.
How RNAZ’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for RNAZ stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.04.
RNAZ Stock Stochastic Average
As of today, the raw stochastic average of TransCode Therapeutics Inc over the last 50 days is at 0.53%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 12.35%. Further, the company’s Stochastic %K and %D values for the last 20 days were 29.52% and 50.21%, respectively.
RNAZ Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -90.97% this year. Over the last six months, there has been a stronger performance of -98.35%. The price of RNAZ leaped by -15.00% during the last 30 days period. For the last 5-days stocks have slided -13.41%.
